/

Society

Bl

Not verified

BlueWind Medical, Ltd.

What we write about

BiotechnologyHealthIndustriaMedical and healthMedicine - various

6 Press releases

View all press releases

16/12/2025

Industria

Health

Food hygiene

Medical and health

Tecnica

Biotechnology

BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

29/04/2025

Fairs

Industria

Health

Medical and health

Scienza

Biotechnology

Revi® System Demonstrates Significant and Sustained Quality of Life Benefits Across All Domains for the Majority of Patients with Urgency Urinary Incontinence at 24 Months

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

07/02/2025

Scienza

Tecnica

Medical and health

Medicine - various

Various technologies

Biotechnology

Health

Industria

BlueWind Medical Announces Peer-Reviewed Data Showing Excellent Durability of Results for Revi® System at Two Years

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

04/11/2024

Industria

Scienza

Tecnica

Medical and health

Medicine - various

Biotechnology

Health

BlueWind Medical Announces Favorable CMS Decision for 2025 Reimbursement Rates for Revi® System’s Implantable Tibial Neuromodulation Therapy

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

31/10/2024

Industria

Scienza

Tecnica

Medical and health

Medicine - various

Biotechnology

Health

New Research from BlueWind Medical Shows Implantable Tibial Neuromodulation (iTNM), such as the Revi® System, as Effective Alternative to Sacral Neuromodulation (SNM) for Overactive Bladder and Urge Urinary Incontinence

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

24/10/2024

Industria

Health

Medicine - various

Sanità

Pharmaceuticals

Biotechnology

Two-Year Revi® Therapy Data Reinforce Sustained Efficacy and Safety of Implantable Tibial NeuroModulation in Managing Urgency Urinary Incontinence

Source

BlueWind Medical, Ltd.

Issuer

1.00

0

Followers

0

Compatibility

0